Insider · CIK 0001533149
Suketu Upadhyay
cfoofficerdirector
Files at VRTX (VERTEX PHARMACEUTICALS INC / MA), ZBH (ZIMMER BIOMET HOLDINGS, INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 1, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | AGrant or award Common Stock | +796 | $0.00 | $0 | 3,355 | May 5, 2025 |
| May 1, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | DDisposition to issuer Common Stock | -1,001 | - | - | 2,354 | May 5, 2025 |
| May 1, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | AGrant or award Deferred Stock Unitsderivative | +1,001 | - | - | 2,476 | May 5, 2025 |
| Apr 15, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | AGrant or award Deferred Stock Unitsderivative | +72 | $497.51 | $36k | 1,475 | Apr 17, 2025 |
| Nov 10, 2024 | ZBH ZIMMER BIOMET HOLDINGS, INC. | MOption exercise Common Stock | +15,948 | $0.00 | $0 | 36,842 | Nov 12, 2024 |
| Nov 10, 2024 | ZBH ZIMMER BIOMET HOLDINGS, INC. | FTax withholding Common Stock | -7,097 | $108.48 | $770k | 29,745 | Nov 12, 2024 |
| Nov 8, 2024 | ZBH ZIMMER BIOMET HOLDINGS, INC. | AGrant or award Restricted Stock Unitsderivative | +15,948 | $0.00 | $0 | 15,948 | Nov 12, 2024 |
| Nov 10, 2024 | ZBH ZIMMER BIOMET HOLDINGS, INC. | MOption exercise Restricted Stock Unitsderivative | -15,948 | $0.00 | $0 | 0 | Nov 12, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.